Biochemical and Stone-Risk Profiles With Topiramate Treatment

American Journal of Kidney Diseases

Volumn 48, Issue 4, 2006, Pages 555-563

  Welch, Brian J ^a   Graybeal, Dion ^a   Moe, Orson W ^a   Maalouf, Naim M ^a   Sakhaee, Khashayar ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

kidney stones; nephrolithiasis; Topiramate

Indexed keywords

BICARBONATE; CALCIUM PHOSPHATE DIBASIC; CITRIC ACID; TOPIRAMATE; URIC ACID;

ADULT; ARTICLE; BICARBONATE BLOOD LEVEL; BIOCHEMISTRY; CALCIUM STONE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METABOLIC ACIDOSIS; RISK ASSESSMENT; RISK FACTOR; URINARY EXCRETION; URINE LEVEL; URINE PH;

ACID-BASE EQUILIBRIUM; ACIDOSIS; ADULT; BICARBONATES; CALCIUM PHOSPHATES; CITRATES; CROSS-SECTIONAL STUDIES; FEMALE; FRUCTOSE; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY CALCULI; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS;

EID: 33748744783     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.07.003     Document Type: Article

References (34)

1. Topamax (topiramate) package insert. Raritan, NJ, Ortho-McNeil Pharmaceuticals. Available at: www.topamax.com. Accessed July 12, 2006
2. DeLorenzo R.J., Sombati S., and Coulter D.A. Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons. Epilepsia 41 suppl 1 (2000) S40-S44
3. Gibbs J.W., Sombati S., Delorenzo R.J., and Coulter D.A. Cellular actions of topiramate: Blockade of kainite-evoked inward currents in cultured hippocampal neurons. Epilepsia 41 suppl 1 (2000) S10-S16
4. Skradski S., and White H.S. Topiramate blocks kainite-evoked cobalt influx into cultured neurons. Epilepsia 41 suppl 1 (2000) S45-S47
5. Shank R.P., Gardocki J.F., Streeter A.J., and Maryanoff B.E. An overview of the preclinical aspects of TPM: Pharmacology, pharmacokinetics, and mechanisms of action. Epilepsia 41 suppl 1 (2000) S3-S9
6. Dodgson S.J., Shank R.P., and Maryanoff B.E. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41 suppl 1 (2000) S35-S39
7. Schwartz G.J., Olson J., Kittelberger A.M., Matsumoto T., Waheed A., and Sly W.S. Postnatal development of carbonic anhydrase IV expression in rabbit kidney. Am J Physiol 276 (1999) F510-F520
8. Brown D., Zhu X.L., and Sly W.S. Localization of membrane-associated carbonic anhydrase type IV in kidney epithelial cells. Proc Natl Acad Sci U S A 87 (1990) 7457-7461
9. Brown D., Kumpulainen T., Roth J., and Orci L. Immunohistochemical localization of carbonic anhydrase in postnatal and adult rat kidney. Am J Physiol 245 (1983) F110-F118
10. Lamb E.J., Stevens P.E., and Nashef L. Topiramate increases biochemical risk of nephrolithiasis. Ann Clin Biochem 41 (2004) 166-169
11. Kuo R.L., Moran M.E., Kim D.H., Abrahams H.M., White M.D., and Lingeman J.E. Topiramate-induced nephrolithiasis. J Endourol 16 (2002) 229-231
12. Shorvon S.D. Safety of topiramate: Adverse events and relationship to dosing. Epilepsia 37 suppl 21 (1996) S18-S22
13. Eggener S., Kim S.C., User H.M., Pazona J., and Nadler R.B. Urolithiasis associated with topiramate. Int Braz J Urol 30 (2004) 29-30
14. Takhar J., and Manchanda R. Nephrolithiasis on topiramate therapy. Can J Psychiatry 45 (2000) 491-493
15. Pak C.Y.C., Skurla C., and Harvey J. Graphic display of urinary risk factors for renal stone formation. J Urol 134 (1985) 867-870
16. Werness P.G., Brown C.M., Smith L.H., and Finlayson B. EQUIL2: A basic computer program for the calculation of urinary saturation. J Urol 134 (1985) 1242-1244
17. Sakhaee K., Williams R.H., Oh M.S., et al. Alkali absorption and citrate excretion in calcium nephrolithiasis. J Bone Miner Res 8 (1993) 789-794
18. Pak C.Y.C. Citrate and renal calculi. Miner Electrolyte Metab 13 (1987) 257-266
19. Pak C.Y., and Adams-Huet B. Elucidation of factors determining formation of calcium phosphate stones. J Urol 172 (2004) 2267-2270
20. Coe F.L., Evan A., and Worcester E. Kidney stone disease. J Clin Invest 115 (2005) 2598-2608
21. Hamm L.L., and Hering-Smith K.S. Pathophysiology of hypocitraturic nephrolithiasis. Endocrinol Metab Clin North Am 4 (2002) 885-893
22. Aruga S., Wehrli S., Kaissling B., et al. Chronic metabolic acidosis increases NaDC-1 mRNA and protein in rat kidney. Kidney Int 58 (2000) 206-215
23. Melnick J.Z., Preisig P.A., Moe O.W., Srere P., and Alpern R.J. Renal cortical mitochondrial aconitase is regulated in hypo- and hypercitraturia. Kidney Int 54 (1998) 160-165
24. Melnick J.Z., Srere P.A., Elshourbagy N.A., Moe O.W., Preisig P.A., and Alpern R.J. Adenosine triphosphate citrate lyase mediates hypocitraturia in rats. J Clin Invest 98 (1996) 2381-2387
25. Jenkins A.D., Dousa T.P., and Smith L.H. Transport of citrate across renal brush border membrane: Effects of dietary acid and alkali loading. Am J Physiol 249 (1985) F590-F595
26. Vainsel M., Fondu P., Cadranel S., Rocmans C., and Gepts W. Osteopetrosis associated with proximal and distal tubular acidosis. Acta Paediatr Scand 61 (1972) 429-434
27. Ohlsson A., Cumming W.A., Paul A., and Sly W.S. Carbonic anhydrase II deficiency syndrome: Recessive osteopetrosis with renal tubular acidosis and cerebral calcification. Pediatrics 77 (1986) 371-380
28. Bregman H., Brown J., Rogers A., and Burke E. Osteopetrosis with combined proximal and distal renal tubular acidosis. Am J Kidney Dis 11 (1982) 357-362
29. Nagai R., Kooh S.W., Balfe J.W., Fenton T., and Halperin M.L. Renal tubular acidosis and osteopetrosis with carbonic anhydrase II deficiency: Pathogenesis of impaired acidification. Pediatr Nephrol 11 (1997) 633-636
30. Gordon E.E., and Sheps S.G. Effect of acetazolamide on citrate excretion and formation of renal calculi. Report of a case and study of five normal subjects. N Engl J Med 256 (1957) 1215-1219
31. Hanley T., and Platts M.M. Observations on the metabolic effects of the carbonic anhydrase inhibitor diamox: Mode and rate of recovery from the drug's action. J Clin Invest 35 (1956) 20-30
32. Nicar M.J., Skurla C., Sakhaee K., and Pak C.Y. Low urinary citrate excretion in nephrolithiasis. Urology 21 (1983) 8-14
33. Preminger G.M., Sakhaee K., Skurla C., and Pak C.Y. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol 134 (1985) 20-23
34. Pak C.Y. Prevention and treatment of kidney stones. Role of medical prevention. J Urol 141 (1989) 798-801